These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30226599)

  • 21. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
    Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
    Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
    Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
    J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs.
    Woltering EA; Lewis JM; Maxwell PJ; Frey DJ; Wang YZ; Rothermel J; Anthony CT; Balster DA; O'Leary JP; Harrison LH
    Ann Surg; 2003 Jun; 237(6):790-8; discussion 798-800. PubMed ID: 12796575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
    Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
    Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancer.
    Wang B; Yu W; Guo J; Jiang X; Lu W; Liu M; Pang X
    J Pharmacol Exp Ther; 2015 Jan; 352(1):129-38. PubMed ID: 25352499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
    Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH
    J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model.
    Kramer-Marek G; Gijsen M; Kiesewetter DO; Bennett R; Roxanis I; Zielinski R; Kong A; Capala J
    J Nucl Med; 2012 Apr; 53(4):629-37. PubMed ID: 22410461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.
    Dassler K; Scholle FD; Schütz G
    Magn Reson Med; 2014 May; 71(5):1826-33. PubMed ID: 23754607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.
    Sarkar C; Chakroborty D; Dasgupta PS; Basu S
    Int J Cancer; 2015 Aug; 137(3):744-9. PubMed ID: 25556636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
    Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
    Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic agent SU6668 suppresses the tumor growth of xenografted A-431 cells.
    Nakamura T; Ozawa S; Kitagawa Y; Ueda M; Kubota T; Kitajima M
    Oncol Rep; 2006 Jan; 15(1):79-83. PubMed ID: 16328037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radionuclide imaging of tumor angiogenesis.
    Dijkgraaf I; Boerman OC
    Cancer Biother Radiopharm; 2009 Dec; 24(6):637-47. PubMed ID: 20025543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts.
    Rofstad EK; Henriksen K; Galappathi K; Mathiesen B
    Cancer Res; 2003 Jul; 63(14):4055-61. PubMed ID: 12874006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM; Anthony CT; Thomson JL; Woltering EA
    Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.